English
简体中文
Total: £ 56.28
Published Date: 2026-04-24 | Pages: 118 | Tables: 119 | Pharma & Healthcare
The global Antipyretic and Analgesic Drugs market was valued at US$ 14820 million in 2025 and is anticipated to reach US$ 17670 million by 2032, at a CAGR of 2.6% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Antipyretic and Analgesic Drugs competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Antipyretic and analgesic drugs are drugs that can restore the body temperature of patients with fever to normal, but have no effect on normal body temperature. These drugs also have moderate analgesic effects, but their intensity is not as strong as morphine and its synthetic substitutes. Commonly used antipyretic and analgesic drugs can be divided into salicylates, anilines, and pyrazolones based on their chemical structure. Except for anilines, all of these drugs have anti-rheumatic effects and can also treat rheumatism and rheumatoid arthritis. This report covers the market for active pharmaceutical ingredients (APIs) for antipyretic and analgesic drugs. In 2024, global Antipyretic and analgesic drugs production reached approximately Antipyretic and analgesic drugs 360.79 K MT, with an average global market price of around US$ 42.01 per kg.
China and India are two major producers of antipyretic and analgesic drugs, accounting for 51.32% and 18.42% of the market share, respectively, in 2024. China is expected to maintain the fastest growth rate in the coming years, with its share projected to reach 54.06% by 2031. China has sufficient production capacity for antipyretic and analgesic drugs and is actively expanding into the international market. Its global share is expected to gradually increase by 2031. In terms of product type, paracetamol holds a significant position, with a projected share of 42.16% by 2031. At the same time, in terms of application, the share of adults in 2024 will be approximately 75.37%, and the CAGR in the next few years will be approximately 2.49%.
This report delivers a comprehensive overview of the global Antipyretic and Analgesic Drugs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Antipyretic and Analgesic Drugs. The Antipyretic and Analgesic Drugs market size, estimates, and forecasts are provided in terms of sales volume (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Antipyretic and Analgesic Drugs market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Antipyretic and Analgesic Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Xinhua Pharmaceutical Company Limited
Mallinckrodt Pharmaceuticals
Jiheng Pharmaceutical Co., Ltd
Lu'an Pharmaceutical Co., Ltd.
BASF
Seqens
IOL
Granules India
Wuyao Pharmaceutical Co., Ltd
Biocause Heilen Pharmaceutical Co., Ltd
Kangle Pharmaceutical CO., LTD
Fengyuan Pharmaceutical Co., Ltd.
Haisen Pharmaceutical Co., Ltd
Jingye Medical Technology Co., Ltd
Liaoyuan Baikang Pharmaceutical Co., Ltd
Segment by Type
Paracetamol
Aspirin
Ibuprofen
Naproxen
Diclofenac
Oxapzin
Dexibuprofen
Anagen
Others
by Application
Aldult
Child
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Antipyretic and Analgesic Drugs manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Antipyretic and Analgesic Drugs sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Antipyretic and Analgesic Drugs Market Overview
1.1 Product Definition
1.2 Antipyretic and Analgesic Drugs by Type
1.2.1 Global Antipyretic and Analgesic Drugs Market Value by Type: 2025 vs 2032
1.2.2 Paracetamol
1.2.3 Aspirin
1.2.4 Ibuprofen
1.2.5 Naproxen
1.2.6 Diclofenac
1.2.7 Oxapzin
1.2.8 Dexibuprofen
1.2.9 Anagen
1.2.10 Others
1.3 Antipyretic and Analgesic Drugs by Application
1.3.1 Global Antipyretic and Analgesic Drugs Market Value by Application: 2025 vs 2032
1.3.2 Aldult
1.3.3 Child
1.4 Global Antipyretic and Analgesic Drugs Market Size Estimates and Forecasts
1.4.1 Global Antipyretic and Analgesic Drugs Revenue 2021–2032
1.4.2 Global Antipyretic and Analgesic Drugs Sales 2021–2032
1.4.3 Global Antipyretic and Analgesic Drugs Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Antipyretic and Analgesic Drugs Market Competition by Manufacturers
2.1 Global Antipyretic and Analgesic Drugs Sales Market Share by Manufacturers (2021–2026)
2.2 Global Antipyretic and Analgesic Drugs Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Antipyretic and Analgesic Drugs Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Antipyretic and Analgesic Drugs, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Antipyretic and Analgesic Drugs, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Antipyretic and Analgesic Drugs, Product Types and Applications
2.7 Global Key Manufacturers of Antipyretic and Analgesic Drugs, Date of Entry into the Industry
2.8 Global Antipyretic and Analgesic Drugs Market Competitive Situation and Trends
2.8.1 Global Antipyretic and Analgesic Drugs Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Antipyretic and Analgesic Drugs Players Market Share by Revenue
2.8.3 Global Antipyretic and Analgesic Drugs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Antipyretic and Analgesic Drugs Market Scenario by Region
3.1 Global Antipyretic and Analgesic Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Antipyretic and Analgesic Drugs Sales by Region: 2021–2032
3.2.1 Global Antipyretic and Analgesic Drugs Sales by Region: 2021–2026
3.2.2 Global Antipyretic and Analgesic Drugs Sales by Region: 2027–2032
3.3 Global Antipyretic and Analgesic Drugs Revenue by Region: 2021–2032
3.3.1 Global Antipyretic and Analgesic Drugs Revenue by Region: 2021–2026
3.3.2 Global Antipyretic and Analgesic Drugs Revenue by Region: 2027–2032
3.4 North America Antipyretic and Analgesic Drugs Market Facts & Figures by Country
3.4.1 North America Antipyretic and Analgesic Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Antipyretic and Analgesic Drugs Sales by Country (2021–2032)
3.4.3 North America Antipyretic and Analgesic Drugs Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Antipyretic and Analgesic Drugs Market Facts & Figures by Country
3.5.1 Europe Antipyretic and Analgesic Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Antipyretic and Analgesic Drugs Sales by Country (2021–2032)
3.5.3 Europe Antipyretic and Analgesic Drugs Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antipyretic and Analgesic Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Antipyretic and Analgesic Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Antipyretic and Analgesic Drugs Sales by Region (2021–2032)
3.6.3 Asia Pacific Antipyretic and Analgesic Drugs Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Antipyretic and Analgesic Drugs Market Facts & Figures by Country
3.7.1 Latin America Antipyretic and Analgesic Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Antipyretic and Analgesic Drugs Sales by Country (2021–2032)
3.7.3 Latin America Antipyretic and Analgesic Drugs Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antipyretic and Analgesic Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Antipyretic and Analgesic Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Antipyretic and Analgesic Drugs Sales by Country (2021–2032)
3.8.3 Middle East and Africa Antipyretic and Analgesic Drugs Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Antipyretic and Analgesic Drugs Sales by Type (2021–2032)
4.1.1 Global Antipyretic and Analgesic Drugs Sales by Type (2021–2026)
4.1.2 Global Antipyretic and Analgesic Drugs Sales by Type (2027–2032)
4.1.3 Global Antipyretic and Analgesic Drugs Sales Market Share by Type (2021–2032)
4.2 Global Antipyretic and Analgesic Drugs Revenue by Type (2021–2032)
4.2.1 Global Antipyretic and Analgesic Drugs Revenue by Type (2021–2026)
4.2.2 Global Antipyretic and Analgesic Drugs Revenue by Type (2027–2032)
4.2.3 Global Antipyretic and Analgesic Drugs Revenue Market Share by Type (2021–2032)
4.3 Global Antipyretic and Analgesic Drugs Price by Type (2021–2032)
5 Segment by Application
5.1 Global Antipyretic and Analgesic Drugs Sales by Application (2021–2032)
5.1.1 Global Antipyretic and Analgesic Drugs Sales by Application (2021–2026)
5.1.2 Global Antipyretic and Analgesic Drugs Sales by Application (2027–2032)
5.1.3 Global Antipyretic and Analgesic Drugs Sales Market Share by Application (2021–2032)
5.2 Global Antipyretic and Analgesic Drugs Revenue by Application (2021–2032)
5.2.1 Global Antipyretic and Analgesic Drugs Revenue by Application (2021–2026)
5.2.2 Global Antipyretic and Analgesic Drugs Revenue by Application (2027–2032)
5.2.3 Global Antipyretic and Analgesic Drugs Revenue Market Share by Application (2021–2032)
5.3 Global Antipyretic and Analgesic Drugs Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Xinhua Pharmaceutical Company Limited
6.1.1 Xinhua Pharmaceutical Company Limited Company Information
6.1.2 Xinhua Pharmaceutical Company Limited Description and Business Overview
6.1.3 Xinhua Pharmaceutical Company Limited Antipyretic and Analgesic Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Xinhua Pharmaceutical Company Limited Antipyretic and Analgesic Drugs Product Portfolio
6.1.5 Xinhua Pharmaceutical Company Limited Recent Developments/Updates
6.2 Mallinckrodt Pharmaceuticals
6.2.1 Mallinckrodt Pharmaceuticals Company Information
6.2.2 Mallinckrodt Pharmaceuticals Description and Business Overview
6.2.3 Mallinckrodt Pharmaceuticals Antipyretic and Analgesic Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Mallinckrodt Pharmaceuticals Antipyretic and Analgesic Drugs Product Portfolio
6.2.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
6.3 Jiheng Pharmaceutical Co., Ltd
6.3.1 Jiheng Pharmaceutical Co., Ltd Company Information
6.3.2 Jiheng Pharmaceutical Co., Ltd Description and Business Overview
6.3.3 Jiheng Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Jiheng Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Product Portfolio
6.3.5 Jiheng Pharmaceutical Co., Ltd Recent Developments/Updates
6.4 Lu'an Pharmaceutical Co., Ltd.
6.4.1 Lu'an Pharmaceutical Co., Ltd. Company Information
6.4.2 Lu'an Pharmaceutical Co., Ltd. Description and Business Overview
6.4.3 Lu'an Pharmaceutical Co., Ltd. Antipyretic and Analgesic Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Lu'an Pharmaceutical Co., Ltd. Antipyretic and Analgesic Drugs Product Portfolio
6.4.5 Lu'an Pharmaceutical Co., Ltd. Recent Developments/Updates
6.5 BASF
6.5.1 BASF Company Information
6.5.2 BASF Description and Business Overview
6.5.3 BASF Antipyretic and Analgesic Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 BASF Antipyretic and Analgesic Drugs Product Portfolio
6.5.5 BASF Recent Developments/Updates
6.6 Seqens
6.6.1 Seqens Company Information
6.6.2 Seqens Description and Business Overview
6.6.3 Seqens Antipyretic and Analgesic Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Seqens Antipyretic and Analgesic Drugs Product Portfolio
6.6.5 Seqens Recent Developments/Updates
6.7 IOL
6.7.1 IOL Company Information
6.7.2 IOL Description and Business Overview
6.7.3 IOL Antipyretic and Analgesic Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 IOL Antipyretic and Analgesic Drugs Product Portfolio
6.7.5 IOL Recent Developments/Updates
6.8 Granules India
6.8.1 Granules India Company Information
6.8.2 Granules India Description and Business Overview
6.8.3 Granules India Antipyretic and Analgesic Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Granules India Antipyretic and Analgesic Drugs Product Portfolio
6.8.5 Granules India Recent Developments/Updates
6.9 Wuyao Pharmaceutical Co., Ltd
6.9.1 Wuyao Pharmaceutical Co., Ltd Company Information
6.9.2 Wuyao Pharmaceutical Co., Ltd Description and Business Overview
6.9.3 Wuyao Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Wuyao Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Product Portfolio
6.9.5 Wuyao Pharmaceutical Co., Ltd Recent Developments/Updates
6.10 Biocause Heilen Pharmaceutical Co., Ltd
6.10.1 Biocause Heilen Pharmaceutical Co., Ltd Company Information
6.10.2 Biocause Heilen Pharmaceutical Co., Ltd Description and Business Overview
6.10.3 Biocause Heilen Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Biocause Heilen Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Product Portfolio
6.10.5 Biocause Heilen Pharmaceutical Co., Ltd Recent Developments/Updates
6.11 Kangle Pharmaceutical CO., LTD
6.11.1 Kangle Pharmaceutical CO., LTD Company Information
6.11.2 Kangle Pharmaceutical CO., LTD Description and Business Overview
6.11.3 Kangle Pharmaceutical CO., LTD Antipyretic and Analgesic Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Kangle Pharmaceutical CO., LTD Antipyretic and Analgesic Drugs Product Portfolio
6.11.5 Kangle Pharmaceutical CO., LTD Recent Developments/Updates
6.12 Fengyuan Pharmaceutical Co., Ltd.
6.12.1 Fengyuan Pharmaceutical Co., Ltd. Company Information
6.12.2 Fengyuan Pharmaceutical Co., Ltd. Description and Business Overview
6.12.3 Fengyuan Pharmaceutical Co., Ltd. Antipyretic and Analgesic Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Fengyuan Pharmaceutical Co., Ltd. Antipyretic and Analgesic Drugs Product Portfolio
6.12.5 Fengyuan Pharmaceutical Co., Ltd. Recent Developments/Updates
6.13 Haisen Pharmaceutical Co., Ltd
6.13.1 Haisen Pharmaceutical Co., Ltd Company Information
6.13.2 Haisen Pharmaceutical Co., Ltd Description and Business Overview
6.13.3 Haisen Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Haisen Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Product Portfolio
6.13.5 Haisen Pharmaceutical Co., Ltd Recent Developments/Updates
6.14 Jingye Medical Technology Co., Ltd
6.14.1 Jingye Medical Technology Co., Ltd Company Information
6.14.2 Jingye Medical Technology Co., Ltd Description and Business Overview
6.14.3 Jingye Medical Technology Co., Ltd Antipyretic and Analgesic Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Jingye Medical Technology Co., Ltd Antipyretic and Analgesic Drugs Product Portfolio
6.14.5 Jingye Medical Technology Co., Ltd Recent Developments/Updates
6.15 Liaoyuan Baikang Pharmaceutical Co., Ltd
6.15.1 Liaoyuan Baikang Pharmaceutical Co., Ltd Company Information
6.15.2 Liaoyuan Baikang Pharmaceutical Co., Ltd Description and Business Overview
6.15.3 Liaoyuan Baikang Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Liaoyuan Baikang Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Product Portfolio
6.15.5 Liaoyuan Baikang Pharmaceutical Co., Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antipyretic and Analgesic Drugs Industry Chain Analysis
7.2 Antipyretic and Analgesic Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antipyretic and Analgesic Drugs Production Mode & Process Analysis
7.4 Antipyretic and Analgesic Drugs Sales and Marketing
7.4.1 Antipyretic and Analgesic Drugs Sales Channels
7.4.2 Antipyretic and Analgesic Drugs Distributors
7.5 Antipyretic and Analgesic Drugs Customer Analysis
8 Antipyretic and Analgesic Drugs Market Dynamics
8.1 Antipyretic and Analgesic Drugs Industry Trends
8.2 Antipyretic and Analgesic Drugs Market Drivers
8.3 Antipyretic and Analgesic Drugs Market Challenges
8.4 Antipyretic and Analgesic Drugs Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Antipyretic and Analgesic Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Antipyretic and Analgesic Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Antipyretic and Analgesic Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Antipyretic and Analgesic Drugs Sales (K MT) of Key Manufacturers (2021–2026)
Table 5. Global Antipyretic and Analgesic Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Antipyretic and Analgesic Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Antipyretic and Analgesic Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Antipyretic and Analgesic Drugs Average Price (US$/kg) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Antipyretic and Analgesic Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Antipyretic and Analgesic Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Antipyretic and Analgesic Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of Antipyretic and Analgesic Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Antipyretic and Analgesic Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Antipyretic and Analgesic Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Antipyretic and Analgesic Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Antipyretic and Analgesic Drugs Sales by Region (K MT), 2021–2026
Table 18. Global Antipyretic and Analgesic Drugs Sales Market Share by Region (2021–2026)
Table 19. Global Antipyretic and Analgesic Drugs Sales by Region (K MT), 2027–2032
Table 20. Global Antipyretic and Analgesic Drugs Sales Market Share by Region (2027–2032)
Table 21. Global Antipyretic and Analgesic Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Antipyretic and Analgesic Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global Antipyretic and Analgesic Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Antipyretic and Analgesic Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America Antipyretic and Analgesic Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Antipyretic and Analgesic Drugs Sales by Country (K MT), 2021–2026
Table 27. North America Antipyretic and Analgesic Drugs Sales by Country (K MT), 2027–2032
Table 28. North America Antipyretic and Analgesic Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Antipyretic and Analgesic Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Antipyretic and Analgesic Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Antipyretic and Analgesic Drugs Sales by Country (K MT), 2021–2026
Table 32. Europe Antipyretic and Analgesic Drugs Sales by Country (K MT), 2027–2032
Table 33. Europe Antipyretic and Analgesic Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Antipyretic and Analgesic Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Antipyretic and Analgesic Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Antipyretic and Analgesic Drugs Sales by Region (K MT), 2021–2026
Table 37. Asia Pacific Antipyretic and Analgesic Drugs Sales by Region (K MT), 2027–2032
Table 38. Asia Pacific Antipyretic and Analgesic Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Antipyretic and Analgesic Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Antipyretic and Analgesic Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Antipyretic and Analgesic Drugs Sales by Country (K MT), 2021–2026
Table 42. Latin America Antipyretic and Analgesic Drugs Sales by Country (K MT), 2027–2032
Table 43. Latin America Antipyretic and Analgesic Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Antipyretic and Analgesic Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Antipyretic and Analgesic Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Antipyretic and Analgesic Drugs Sales by Country (K MT), 2021–2026
Table 47. Middle East and Africa Antipyretic and Analgesic Drugs Sales by Country (K MT), 2027–2032
Table 48. Middle East and Africa Antipyretic and Analgesic Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Antipyretic and Analgesic Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Antipyretic and Analgesic Drugs Sales (K MT) by Type (2021–2026)
Table 51. Global Antipyretic and Analgesic Drugs Sales (K MT) by Type (2027–2032)
Table 52. Global Antipyretic and Analgesic Drugs Sales Market Share by Type (2021–2026)
Table 53. Global Antipyretic and Analgesic Drugs Sales Market Share by Type (2027–2032)
Table 54. Global Antipyretic and Analgesic Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Antipyretic and Analgesic Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Antipyretic and Analgesic Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global Antipyretic and Analgesic Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global Antipyretic and Analgesic Drugs Price (US$/kg) by Type (2021–2026)
Table 59. Global Antipyretic and Analgesic Drugs Price (US$/kg) by Type (2027–2032)
Table 60. Global Antipyretic and Analgesic Drugs Sales (K MT) by Application (2021–2026)
Table 61. Global Antipyretic and Analgesic Drugs Sales (K MT) by Application (2027–2032)
Table 62. Global Antipyretic and Analgesic Drugs Sales Market Share by Application (2021–2026)
Table 63. Global Antipyretic and Analgesic Drugs Sales Market Share by Application (2027–2032)
Table 64. Global Antipyretic and Analgesic Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Antipyretic and Analgesic Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Antipyretic and Analgesic Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global Antipyretic and Analgesic Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global Antipyretic and Analgesic Drugs Price (US$/kg) by Application (2021–2026)
Table 69. Global Antipyretic and Analgesic Drugs Price (US$/kg) by Application (2027–2032)
Table 70. Xinhua Pharmaceutical Company Limited Company Information
Table 71. Xinhua Pharmaceutical Company Limited Description and Business Overview
Table 72. Xinhua Pharmaceutical Company Limited Antipyretic and Analgesic Drugs Sales (K MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 73. Xinhua Pharmaceutical Company Limited Antipyretic and Analgesic Drugs Product
Table 74. Xinhua Pharmaceutical Company Limited Recent Developments/Updates
Table 75. Mallinckrodt Pharmaceuticals Company Information
Table 76. Mallinckrodt Pharmaceuticals Description and Business Overview
Table 77. Mallinckrodt Pharmaceuticals Antipyretic and Analgesic Drugs Sales (K MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 78. Mallinckrodt Pharmaceuticals Antipyretic and Analgesic Drugs Product
Table 79. Mallinckrodt Pharmaceuticals Recent Developments/Updates
Table 80. Jiheng Pharmaceutical Co., Ltd Company Information
Table 81. Jiheng Pharmaceutical Co., Ltd Description and Business Overview
Table 82. Jiheng Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Sales (K MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 83. Jiheng Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Product
Table 84. Jiheng Pharmaceutical Co., Ltd Recent Developments/Updates
Table 85. Lu'an Pharmaceutical Co., Ltd. Company Information
Table 86. Lu'an Pharmaceutical Co., Ltd. Description and Business Overview
Table 87. Lu'an Pharmaceutical Co., Ltd. Antipyretic and Analgesic Drugs Sales (K MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 88. Lu'an Pharmaceutical Co., Ltd. Antipyretic and Analgesic Drugs Product
Table 89. Lu'an Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 90. BASF Company Information
Table 91. BASF Description and Business Overview
Table 92. BASF Antipyretic and Analgesic Drugs Sales (K MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 93. BASF Antipyretic and Analgesic Drugs Product
Table 94. BASF Recent Developments/Updates
Table 95. Seqens Company Information
Table 96. Seqens Description and Business Overview
Table 97. Seqens Antipyretic and Analgesic Drugs Sales (K MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 98. Seqens Antipyretic and Analgesic Drugs Product
Table 99. Seqens Recent Developments/Updates
Table 100. IOL Company Information
Table 101. IOL Description and Business Overview
Table 102. IOL Antipyretic and Analgesic Drugs Sales (K MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 103. IOL Antipyretic and Analgesic Drugs Product
Table 104. IOL Recent Developments/Updates
Table 105. Granules India Company Information
Table 106. Granules India Description and Business Overview
Table 107. Granules India Antipyretic and Analgesic Drugs Sales (K MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 108. Granules India Antipyretic and Analgesic Drugs Product
Table 109. Granules India Recent Developments/Updates
Table 110. Wuyao Pharmaceutical Co., Ltd Company Information
Table 111. Wuyao Pharmaceutical Co., Ltd Description and Business Overview
Table 112. Wuyao Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Sales (K MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 113. Wuyao Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Product
Table 114. Wuyao Pharmaceutical Co., Ltd Recent Developments/Updates
Table 115. Biocause Heilen Pharmaceutical Co., Ltd Company Information
Table 116. Biocause Heilen Pharmaceutical Co., Ltd Description and Business Overview
Table 117. Biocause Heilen Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Sales (K MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 118. Biocause Heilen Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Product
Table 119. Biocause Heilen Pharmaceutical Co., Ltd Recent Developments/Updates
Table 120. Kangle Pharmaceutical CO., LTD Company Information
Table 121. Kangle Pharmaceutical CO., LTD Description and Business Overview
Table 122. Kangle Pharmaceutical CO., LTD Antipyretic and Analgesic Drugs Sales (K MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 123. Kangle Pharmaceutical CO., LTD Antipyretic and Analgesic Drugs Product
Table 124. Kangle Pharmaceutical CO., LTD Recent Developments/Updates
Table 125. Fengyuan Pharmaceutical Co., Ltd. Company Information
Table 126. Fengyuan Pharmaceutical Co., Ltd. Description and Business Overview
Table 127. Fengyuan Pharmaceutical Co., Ltd. Antipyretic and Analgesic Drugs Sales (K MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 128. Fengyuan Pharmaceutical Co., Ltd. Antipyretic and Analgesic Drugs Product
Table 129. Fengyuan Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 130. Haisen Pharmaceutical Co., Ltd Company Information
Table 131. Haisen Pharmaceutical Co., Ltd Description and Business Overview
Table 132. Haisen Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Sales (K MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 133. Haisen Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Product
Table 134. Haisen Pharmaceutical Co., Ltd Recent Developments/Updates
Table 135. Jingye Medical Technology Co., Ltd Company Information
Table 136. Jingye Medical Technology Co., Ltd Description and Business Overview
Table 137. Jingye Medical Technology Co., Ltd Antipyretic and Analgesic Drugs Sales (K MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 138. Jingye Medical Technology Co., Ltd Antipyretic and Analgesic Drugs Product
Table 139. Jingye Medical Technology Co., Ltd Recent Developments/Updates
Table 140. Liaoyuan Baikang Pharmaceutical Co., Ltd Company Information
Table 141. Liaoyuan Baikang Pharmaceutical Co., Ltd Description and Business Overview
Table 142. Liaoyuan Baikang Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Sales (K MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 143. Liaoyuan Baikang Pharmaceutical Co., Ltd Antipyretic and Analgesic Drugs Product
Table 144. Liaoyuan Baikang Pharmaceutical Co., Ltd Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Antipyretic and Analgesic Drugs Distributors List
Table 148. Antipyretic and Analgesic Drugs Customers List
Table 149. Antipyretic and Analgesic Drugs Market Trends
Table 150. Antipyretic and Analgesic Drugs Market Drivers
Table 151. Antipyretic and Analgesic Drugs Market Challenges
Table 152. Antipyretic and Analgesic Drugs Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Antipyretic and Analgesic Drugs
Figure 2. Global Antipyretic and Analgesic Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Antipyretic and Analgesic Drugs Market Share by Type: 2025 & 2032
Figure 4. Paracetamol Product Picture
Figure 5. Aspirin Product Picture
Figure 6. Ibuprofen Product Picture
Figure 7. Naproxen Product Picture
Figure 8. Diclofenac Product Picture
Figure 9. Oxapzin Product Picture
Figure 10. Dexibuprofen Product Picture
Figure 11. Anagen Product Picture
Figure 12. Others Product Picture
Figure 13. Global Antipyretic and Analgesic Drugs Market Value by Application (US$ Million), 2021–2032
Figure 14. Global Antipyretic and Analgesic Drugs Market Share by Application: 2025 & 2032
Figure 15. Aldult
Figure 16. Child
Figure 17. Global Antipyretic and Analgesic Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 18. Global Antipyretic and Analgesic Drugs Market Size (US$ Million), 2021–2032
Figure 19. Global Antipyretic and Analgesic Drugs Sales (K MT), 2021–2032
Figure 20. Global Antipyretic and Analgesic Drugs Average Price (US$/kg), 2021–2032
Figure 21. Antipyretic and Analgesic Drugs Report Years Considered
Figure 22. Antipyretic and Analgesic Drugs Sales Share by Manufacturers in 2025
Figure 23. Global Antipyretic and Analgesic Drugs Revenue Share by Manufacturers in 2025
Figure 24. Top 5 and Top 10 Global Antipyretic and Analgesic Drugs Players: Market Share by Revenue in Antipyretic and Analgesic Drugs in 2025
Figure 25. Antipyretic and Analgesic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 26. Global Antipyretic and Analgesic Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 27. North America Antipyretic and Analgesic Drugs Sales Market Share by Country (2021–2032)
Figure 28. North America Antipyretic and Analgesic Drugs Revenue Market Share by Country (2021–2032)
Figure 29. United States Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Canada Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Europe Antipyretic and Analgesic Drugs Sales Market Share by Country (2021–2032)
Figure 32. Europe Antipyretic and Analgesic Drugs Revenue Market Share by Country (2021–2032)
Figure 33. Germany Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. France Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. U.K. Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Italy Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Russia Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Asia Pacific Antipyretic and Analgesic Drugs Sales Market Share by Region (2021–2032)
Figure 39. Asia Pacific Antipyretic and Analgesic Drugs Revenue Market Share by Region (2021–2032)
Figure 40. China Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Japan Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. South Korea Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. India Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Australia Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. China Taiwan Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Southeast Asia Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Latin America Antipyretic and Analgesic Drugs Sales Market Share by Country (2021–2032)
Figure 48. Latin America Antipyretic and Analgesic Drugs Revenue Market Share by Country (2021–2032)
Figure 49. Mexico Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Brazil Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Argentina Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Middle East and Africa Antipyretic and Analgesic Drugs Sales Market Share by Country (2021–2032)
Figure 53. Middle East and Africa Antipyretic and Analgesic Drugs Revenue Market Share by Country (2021–2032)
Figure 54. Turkey Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Saudi Arabia Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. UAE Antipyretic and Analgesic Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Global Sales Market Share of Antipyretic and Analgesic Drugs by Type (2021–2032)
Figure 58. Global Revenue Market Share of Antipyretic and Analgesic Drugs by Type (2021–2032)
Figure 59. Global Antipyretic and Analgesic Drugs Price (US$/kg) by Type (2021–2032)
Figure 60. Global Sales Market Share of Antipyretic and Analgesic Drugs by Application (2021–2032)
Figure 61. Global Revenue Market Share of Antipyretic and Analgesic Drugs by Application (2021–2032)
Figure 62. Global Antipyretic and Analgesic Drugs Price (US$/kg) by Application (2021–2032)
Figure 63. Antipyretic and Analgesic Drugs Value Chain
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
